Point your AI agent at freehire and let it find you a job.

Get the CLI →

Legend Biotech

Develops cell therapies for the treatment of cancer.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
Discussion
biotechhealthcarepharmaceuticals

Company facts

Founded
2014
Employees
3,000
Headquarters
United States
CEO
Ying Huang, Ph.D.
Type
Public
Listed
NASDAQ: LEGN
Subsidiaries
Legend Biotech USA, Legend Biotech Ireland, Legend Biotech Belgium

About

Legend Biotech is a global, commercial-stage biotechnology company developing, manufacturing, and commercializing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Founded in 2014, our mission is to find, create, and bring novel therapies to patients with life-threatening diseases. We began as an early-stage cell therapy company with a vision set by a group of pioneering scientists focusing on advancing antibody-based therapeutics. Our expertise in immunology and gene editing set the foundation for developing therapies, particularly in the field of Oncology. Over the years, our flagship therapy, CARVYKTI™, was recognized for its success in treating multiple myeloma, illustrating the impact of our innovative approach. We have also expanded our pipeline to include CAR-T, CAR-NK, CAR-γδ T, and non-gene-editing CAR technologies. Our research and clinical trials have been pivotal in establishing our position as a leader in the biotechnology industry, demonstrating our commitment to advancing health solutions for patients.

23 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.

A new version of freehire is available